Journal Article

Reply

Markus Luster

European Journal of Nuclear Medicine and Molecular Imaging, 2004, Volume 31, Number 6, Page 925

• Download PDF (106.5 KB)
• View HTML

Journal Article

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma

Markus Luster, StevenI. Sherman, MonicaC. Skarulis, JamesR. Reynolds and Michael Lassmann, et al.

European Journal of Nuclear Medicine and Molecular Imaging, 2003, Volume 30, Number 10, Pages 1371-1377

• Download PDF (252.1 KB)
• View HTML

Journal Article

Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

Paolo Zanotti-Fregonara, Domenico Rubello and Elif Hindié

European Journal of Nuclear Medicine and Molecular Imaging, 2008, Volume 35, Number 7, Pages 1397-1399

• Download PDF (72.4 KB)
• View HTML

Journal Article

Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium

Daniele Barbaro, Mariano Grosso, Giuseppe Boni, Paola Lapi and Cristina Pasquini, et al.

European Journal of Nuclear Medicine and Molecular Imaging, 2010, Volume 37, Number 2, Pages 242-249

• Download PDF (182.4 KB)
• View HTML

Journal Article

On the effectiveness of recombinant human TSH as a stimulating agent for ¹³¹I treatment of metastatic differentiated thyroid cancer

Paolo Zanotti-Fregonara and Elif Hindié

European Journal of Nuclear Medicine and Molecular Imaging, 2010, Volume 37, Number 12, Pages 2264-2266

• Download PDF (83.3 KB)
• View HTML

Journal Article

Papillary thyroid cancer: Medical management and follow-up

Richard T. Kloos

Current Treatment Options in Oncology, 2005, Volume 6, Number 4, Pages 323-338

• Download PDF (618.5 KB)